111th ANNUAL TECHNICAL MEETING
|
Academy Luncheon and Speaker
Anthony Burgett, Ph.D. University of Oklahoma Health Sciences Center Interdisciplinary Research as a Path to New Drug Molecules and New Biological Discoveries. A limited number of tickets are still available for the Academy Luncheon and can be purchased onsite. |
|
Anthony W. G. Burgett is an Associate Professor in the Dept. of Pharmaceutical Chemistry at the University of Oklahoma Health Sciences, and he is also a Member of the Stephenson Cancer Center in the Cancer Therapeutics Program. Dr. Burgett’s research is an interdisciplinary chemistry and biology program focused on identifying new targets in disease biology for therapeutic development and making new potential drug molecules. Currently, major projects in Dr. Burgett’s laboratory focus on the development of a new potential-cancer specific therapeutic class for ovarian cancer and a novel broad-spectrum antiviral therapeutic program.
A graduate of Jenks High School in Jenks, Oklahoma, Dr. Burgett is a Phi Beta Kappa, magna cum laude graduate of the University of Oklahoma, where he earned separate Bachelor of Science degrees in Microbiology and Biochemistry. As an American Chemical Society Medicinal Chemistry Pre-Doctoral Fellow, Dr. Burgett earned a Ph.D. in Biological Chemistry from Univ. of Texas Southwestern Medical Center. Dr. Burgett’s doctoral research focused on the organic chemistry, drug development, and molecular pharmacology of a new class of anticancer compounds. Dr. Burgett doctoral research, conducted under the direction of Profs. Patrick Harran and Michael Roth, was commercialized for pharmaceutical development. Dr. Burgett was a Susan G. Komen for the Cure Postdoctoral Fellow at Harvard University in the laboratory of Prof. Matthew Shair. His interdisciplinary postdoctoral project focused on identifying the cellular target and mechanism of action of a novel class of anti-cancer natural product compounds.
Returning to Oklahoma, Dr. Burgett began his independent research group as an Assistant Professor in the Dept. of Chemistry and Biochemistry at the University of Oklahoma (Norman); in 2020, Dr. Burgett relocated his research group to the Dept. of Pharmaceutical Sciences at the University of Oklahoma Health Sciences Center (OUHSC). Based on his own experience as an OU undergraduate interested in a future in scientific research, Dr. Burgett, as a faculty member, was committed in providing new opportunities, resources, and mentoring for OU undergrads potentially interested in a future in STEM research. Dr. Burgett helped to obtain and direct multiple National Science Foundation (NSF) grants to provide undergraduate research opportunities. Most importantly, Dr. Burgett created and directed the Four-Year Research Engagement (FYRE) program. The FYRE program was a campus wide program to help inspire develop, mentor, train, and launch OU students into a future of STEM scientific research; approximately 400 OU undergraduates participated in FYRE under Dr. Burgett’s direction.
Also, Dr. Burgett’s research group has produced 6 Ph.Ds and 6 M.S. degrees while providing undergraduate research mentoring for over 40 undergraduate researchers.
A graduate of Jenks High School in Jenks, Oklahoma, Dr. Burgett is a Phi Beta Kappa, magna cum laude graduate of the University of Oklahoma, where he earned separate Bachelor of Science degrees in Microbiology and Biochemistry. As an American Chemical Society Medicinal Chemistry Pre-Doctoral Fellow, Dr. Burgett earned a Ph.D. in Biological Chemistry from Univ. of Texas Southwestern Medical Center. Dr. Burgett’s doctoral research focused on the organic chemistry, drug development, and molecular pharmacology of a new class of anticancer compounds. Dr. Burgett doctoral research, conducted under the direction of Profs. Patrick Harran and Michael Roth, was commercialized for pharmaceutical development. Dr. Burgett was a Susan G. Komen for the Cure Postdoctoral Fellow at Harvard University in the laboratory of Prof. Matthew Shair. His interdisciplinary postdoctoral project focused on identifying the cellular target and mechanism of action of a novel class of anti-cancer natural product compounds.
Returning to Oklahoma, Dr. Burgett began his independent research group as an Assistant Professor in the Dept. of Chemistry and Biochemistry at the University of Oklahoma (Norman); in 2020, Dr. Burgett relocated his research group to the Dept. of Pharmaceutical Sciences at the University of Oklahoma Health Sciences Center (OUHSC). Based on his own experience as an OU undergraduate interested in a future in scientific research, Dr. Burgett, as a faculty member, was committed in providing new opportunities, resources, and mentoring for OU undergrads potentially interested in a future in STEM research. Dr. Burgett helped to obtain and direct multiple National Science Foundation (NSF) grants to provide undergraduate research opportunities. Most importantly, Dr. Burgett created and directed the Four-Year Research Engagement (FYRE) program. The FYRE program was a campus wide program to help inspire develop, mentor, train, and launch OU students into a future of STEM scientific research; approximately 400 OU undergraduates participated in FYRE under Dr. Burgett’s direction.
Also, Dr. Burgett’s research group has produced 6 Ph.Ds and 6 M.S. degrees while providing undergraduate research mentoring for over 40 undergraduate researchers.
